
浏览全部资源
扫码关注微信
1.北京中医药大学中医学院,北京 100029
2.北京中医药大学第三附属医院肿瘤血液科,北京 100029
☒宋凤丽,副主任医师。E-mail:13241867910@163.com
收稿:2023-10-31,
网络首发:2024-05-11,
纸质出版:2024-06-12
移动端阅览
胡汉琼, 苑忠霞, 韩林志, 等. 揿针和针刺防治脾肾两虚型化疗后白细胞减少症:随机对照试验[J]. 中国针灸, 2024,44(6):631-636.
HU Hanqiong, YUAN Zhongxia, HAN Linzhi, et al. Intradermal needling and acupuncture in prevention and treatment of leukopenia after chemotherapy with spleen-kidney deficiency: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2024, 44(6): 631-636.
胡汉琼, 苑忠霞, 韩林志, 等. 揿针和针刺防治脾肾两虚型化疗后白细胞减少症:随机对照试验[J]. 中国针灸, 2024,44(6):631-636. DOI: 10.13703/j.0255-2930.20231031-0003.
HU Hanqiong, YUAN Zhongxia, HAN Linzhi, et al. Intradermal needling and acupuncture in prevention and treatment of leukopenia after chemotherapy with spleen-kidney deficiency: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2024, 44(6): 631-636. DOI: 10.13703/j.0255-2930.20231031-0003.
目的:
2
比较揿针和针刺防治脾肾两虚型化疗后白细胞减少症的临床疗效。
方法:
2
将90例接受化疗的恶性肿瘤患者随机分为揿针组(30例,脱落1例)、针刺组(30例,脱落2例,剔除1例)和对照组(30例)。对照组在化疗的基础上予常规对症治疗;在对照组治疗基础上,揿针组于关元、大椎及双侧膈俞、足三里、肾俞行揿针治疗,留针48 h,隔日1次;在对照组治疗基础上,针刺组于揿针组相同穴位行常规针刺治疗,隔日1次。均从化疗第1天开始,共治疗2周。比较各组患者治疗前及治疗第3、7、14、21天白细胞计数、中性粒细胞计数、血红蛋白含量、血小板计数、Karnofsky功能状态(KPS)评分;于治疗第21天评定白细胞减少症的分度、发生率,记录化疗周期中升白细胞药物使用情况。
结果:
2
治疗第7天,揿针组和针刺组白细胞计数高于对照组(
P
<
0.01,
P
<
0.05)。治疗第14天,揿针组和针刺组血红蛋白含量高于对照组(
P
<
0.01)。治疗第7、14、21天,针刺组血小板计数高于对照组(
P
<
0.01),治疗第14、21天,揿针组血小板计数高于对照组(
P
<
0.01)。各组治疗后各时间点中性粒细胞计数、KPS评分及白细胞减少症分度、白细胞减少症发生率、升白细胞药物使用情况比较,差异无统计学意义(
P
>
0.05)。
结论:
2
揿针和常规针刺在化疗周期中均可升高外周血白细胞计数、血红蛋白含量、血小板计数,减少化疗药物对骨髓造血功能的影响,减轻化疗后骨髓抑制,两种治疗方法疗效相当。
Objective
2
To compare the clinical effect of intradermal needling and acupuncture in prevention and treatment of leukopenia after chemotherapy with spleen-kidney deficiency.
Methods
2
A total of 90 patients with malignant tumor who received chemotherapy were randomly divided into a intradermal needling group (30 cases
1 case dropped out)
an acupuncture group (30 cases
2 cases dropped out
1 case was eliminated) and a control group (30 cases). The control group received conventional symptomatic treatment after chemotherapy. On the basis of the treatment in the control group
the intradermal needling group received intradermal needling at Guanyuan (CV 4)
Dazhui (GV 14) and bilateral Geshu (BL 17)
Zusanli (ST 36)
Shenshu (BL 23)
the needles were retained for 48 h
once every other day. On the basis of the treatment in the control group
the acupuncture group received conventional acupuncture at the same acupoints as the intradermal needling group
once every other day. The treatment started from the first day of chemotherapy
for a total of 2 weeks in the three groups. The white blood cell count
neutrophil count
hemoglobin content
platelet count and Karnofsky performance status (KPS) score before treatment and on 3rd
7th
14th
and 21st days after treatment were compared among the three groups. The incidence and grading of leukopenia and the usage of leukocyte-boosting drug during chemotherapy cycle was recorded.
Results
2
On 7th day after treatment
the white blood cell count in the intradermal needling group and the acupuncture group was higher than that in the control group (
P
<
0.01
P
<
0.05). On the 14th day after treatment
the hemoglobin content in the intradermal needling group and the acupuncture group was higher than that in the control group (
P
<
0.01). On the 7th
14th
and 21st days after treatment
the platelet count in the acupuncture group was higher than that in the control group (
P
<
0.01)
on the 14th and 21st days after treatment
the platelet count in the intradermal needling group was higher than that in the control group (
P
<
0.01). There was no statistic
ally significant difference among the three groups after treatment in terms of neutrophil count
KPS score
incidence and grading of leukopenia
and the usage of leukocyte-boosting drug (
P
>
0.05).
Conclusion
2
Both intradermal needling and acupuncture can effectively increase peripheral blood white blood cell count
hemoglobin content and platelet count during chemotherapy cycle
reduce the toxicity of chemotherapy drug to bone marrow hematopoietic function
and alleviate bone marrow suppression after chemotherapy. The two treatments are equally effective.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621